Media-OutReach Newswire China Dongxiang Announces Interim Results for the First Half of 2018 Reforms Continued with High Dividend Payout Maintained
HKBU-led research develops novel drug delivery system for Gouteng compound for Alzheimer’s disease treatment 1.